MENU
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  • About Us
  • Blog
  • Series
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  1. Home
  2. Life Sciences

Life Sciences– tag –

  • Biotech Investment

    How Did Japanese Pharma Choose and Compete Globally? — A 2015–2025 Strategic Overview

    Introduction Over the past decade, major Japanese pharmaceutical companies have undergone significant evolution amidst global competition. Over the past decade, major Japanese pharmaceutical companies have undergone significant evolution...
    2025-07-06
  • Biotech Investment

    What Did Big Pharma Bet On? — Technology and Therapeutic Trends Seen Through 2015–2025 M&A and Partnerships

    Introduction Between 2015 and 2025, global pharmaceutical giants have expanded into innovative therapeutic areas and pursued internalization or adoption of novel technologies. Between 2015 and 2025, global pharmaceutical giants have expa...
    2025-07-05
1
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語